City
Epaper

'One jab of either Pfizer or Oxford-AstraZeneca offers 90% protection'

By IANS | Updated: March 1, 2021 14:50 IST

New Delhi, March 1 Just one vaccine shot reduces the risk of being hospitalised by Covid-19 by more ...

Open in App

New Delhi, March 1 Just one vaccine shot reduces the risk of being hospitalised by Covid-19 by more than 90 per cent, according to new findings, Daily Mail reported.

Public health officials have told Ministers in the UK that the remarkable results apply for both the Pfizer and Oxford-AstraZeneca vaccine, with the British jab proving slightly more effective, the report said.

The new one-dose vaccination figures were calculated by comparing Covid hospitalisation rates in those who have received their first dose with those of a similar age who haven't.

The report said it helps to explain why the numbers being hospitalised are falling so rapidly in the oldest age groups.

Deaths among the over-75s have dropped by 40 per cent, while the number of over-85s being admitted to intensive care units with Covid has dropped close to zero.

The strong results for the Oxford vaccine are a rebuke to the German authorities, which last month advised against its use in the over-65s, Daily Mail said.

The vaccine developed by Oxford University and AstraZeneca is stunningly effective at preventing recipients becoming seriously ill from Covid 19, new analysis shows.

It is even better than the Pfizer jab at stopping people getting so sick that they need to be admitted to hospital, Ministers have been told, according to the report.

A single shot of either jab cuts the chance of needing hospital treatment by more than 90 per cent, 'real world' results from the NHS vaccination programme show.

"But the Oxford-AstraZeneca vaccine, shunned by millions across Europe because of concerns over trial data, is proving slightly more effective at stopping severe Covid-19 illness than the Pfizer jab", Daily Mail said.

Its apparent superiority even holds among over-70s, The Mail on Sunday understands, vindicating the UK drug regulator's decision to approve it for use in older people.

The figures were calculated by comparing Covid hospitalisation rates across England in those who have received a first dose of vaccine in the NHS rollout, to those of a similar age who have not.

They follow a Scottish study of Covid hospitalisation rates, published last week, which came to similar conclusions. Edinburgh University researchers found that by the fourth week after injection, "the Pfizer and Oxford-AstraZeneca vaccines were shown to reduce the risk of hospitalisation from Covid-19 by up to 85 per cent and 94 per cent, respectively".

Among over-80s, who are at highest risk of severe illness, a single dose cut the risk of needing hospital treatment by 81 per cent from week four onwards, when the results from both types were combined, the report said.

( With inputs from IANS )

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Tags: New DelhiOxfordDaily MailThe new delhi municipal councilExpress ukDelhi south-westPfizerPfizer inc.
Open in App

Related Stories

InternationalUS Government Shutdown: US Embassy in India’s X Account to Pause Regular Updates Until Full Operations Resume

CricketIND-W vs AUS-W, 3rd ODI: Australia Women Win Toss, Opt to Bat Against India in Series Decider; Check Playing XIs

CricketWhy Is India Women’s Cricket Team Wearing a Pink Jersey in IND-W vs AUS-W 3rd ODI 2025 Match?

CricketIND-W vs AUS-W 3rd ODI LIVE Cricket Streaming: When and Where to Watch India Women vs Australia Women Final Match

NationalDelhi: 8 Accused in Vehicle Theft Cases Arrested During Police Patrolling, Stolen Scooters and Bikes Recovered

Health Realted Stories

HealthResearch finds fat may secretly fuel Alzheimer's

HealthBill Gates’ endorsement means India’s innovations hold great promise for Global South

HealthStudy shows size, severity of chikungunya outbreaks unpredictable

HealthHealth industry bodies welcome CGHS’ move to revise rates after 15 years

HealthRajasthan cough syrup deaths: All 19 medicines of pharma firm suspended, 3 officials removed